Study guide

Section 10.4: Return and Reuse of Prescription Medications

Texas MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacy Law Foundations & Regulators

Section 1.1: State and Federal Regulatory Bodies Section 1.2: Structure of Texas Pharmacy Law Section 1.3: TSBP Powers and Administrative Procedures Section 1.4: Inspections, Investigations, and Discipline

2 Chapter 2: Pharmacist Licensure & Continuing Education

Section 2.1: Initial Pharmacist Licensure & Reciprocity Section 2.2: License Renewal & Continuing Education Requirements Section 2.3: Inactive Status, Reinstatement, and Administrative Changes Section 2.4: Impaired Pharmacists & Peer Review Programs

3 Chapter 3: Pharmacy Personnel & Supervision Ratios

Section 3.1: Pharmacist-in-Charge (PIC) Responsibilities and Duties Section 3.2: Pharmacy Technicians and Technician Trainees Section 3.3: Pharmacist-to-Technician Supervision Ratios Section 3.4: Duties of Supportive Personnel

4 Chapter 4: Pharmacy Permits & Facility Classifications

Section 4.1: Texas Pharmacy Permit Classes Section 4.2: Class A (Community) Operations & Facilities Section 4.3: Class C (Institutional/Hospital) Operations & Facilities Section 4.4: Central Processing (Class G) and Non-Resident (Class E)

5 Chapter 5: Prescribers & Prescription Validity

Section 5.1: Texas Prescriptive Authority Section 5.2: General Prescription Requirements Section 5.3: Out-of-State and Canadian/Mexican Prescriptions Section 5.4: Self-Prescribing & Prescribing for Family Members

6 Chapter 6: Controlled Substances Schedules & Registration

Section 6.1: Federal vs. Texas Controlled Substances Schedules Section 6.2: DEA Registration & Texas Controlled Substances Act Section 6.3: Scheduled Listed Chemical Products Section 6.4: Controlled Substance Theft or Loss Reporting

7 Chapter 7: Controlled Substances Prescriptions & Dispensing

Section 7.1: CII Prescription Requirements and Validity Section 7.2: CII Refills, Partial Fills, and Emergency Oral Dispensing Section 7.3: CIII-CV Prescription Requirements, Validity, Refills, and Partial Fills Section 7.4: Opioid 10-day Initial Supply Limit & PMP Mandatory Queries

8 Chapter 8: Prescription Monitoring Program (PMP) & Drug Abuse

Section 8.1: Texas Prescription Monitoring Program Reporting & Database Section 8.2: Naloxone Access and Standing Orders in Texas Section 8.3: Corresponding Responsibility & Red Flags of Diversion Section 8.4: Treatment of Substance Use Disorders

9 Chapter 9: Dispensing Standards & Generic Substitution

Section 9.1: Texas Generic Substitution Law Section 9.2: Patient Counseling and Drug Utilization Review Requirements Section 9.3: Prescription Labeling Requirements in Texas Section 9.4: Poison Prevention Packaging Act & Child-Resistant Containers

10 Chapter 10: Prescription Refills, Transfers & Emergency Dispensing

Section 10.1: Prescription Refill Refusal & Professional Judgment Section 10.2: Prescription Transfer Rules Section 10.3: Emergency Refills (72-hour rule & 30-day natural disaster rule) Section 10.4: Return and Reuse of Prescription Medications

11 Chapter 11: Pharmacy Operations, Security & Recordkeeping

Section 11.1: Pharmacy Security, Alarms & Delivery of Drugs in Texas Section 11.2: General Recordkeeping & Document Retention Requirements Section 11.3: Controlled Substance Inventories Section 11.4: Disposal and Destruction of Controlled Substances

12 Chapter 12: Compounding Standards (Sterile & Non-Sterile)

Section 12.1: Non-Sterile Compounding Regulations Section 12.2: Sterile Compounding Regulations Section 12.3: Hazardous Drug Handling Section 12.4: Compounding Recordkeeping & Quality Control

13 Chapter 13: Specialized Pharmacy Practice & Public Safety

Section 13.1: Collaborative Practice Agreements & Drug Therapy Management Section 13.2: Pharmacist Immunization Authority & Protocol Requirements Section 13.3: Automated Dispensing Devices (Class A, C, and remote sites) Section 13.4: Public Health Laws (HIPAA, OBRA-90, DSCSA Drug Track and Trace)

Section 10.4: Return and Reuse of Prescription Medications

Key Takeaways Explain This Topic AI

In community pharmacy settings, once a dispensed prescription drug has left the pharmacy's physical custody, it cannot be returned to stock, reused, or resold.

Undelivered prescriptions in the will-call bin (which never left the pharmacy's custody) may be returned to stock (RTS) if kept in their original vial with patient info removed.

The expiration date for returned will-call (RTS) medications is the lesser of one year from the original dispensing date or the manufacturer's original expiration date.

Unused, non-controlled medications in original sealed unit-dose packaging may be returned for reuse from licensed nursing homes/LTCFs if they have at least 120 days of shelf life remaining.

Under the Prescription Drug Donation Act, participating pharmacies may accept donated non-controlled medications in sealed packaging to redistribute to indigent patients.

Last updated: July 2026

Return and Reuse of Prescription Medications

Once a prescription medication is dispensed and leaves the pharmacy, its storage environment becomes an unknown variable. Exposure to extreme heat in a car glove box, high humidity in a bathroom cabinet, or potential contamination can compromise a drug's integrity, safety, and potency. To protect the public from adulterated or misbranded medications, Texas pharmacy law enforces a strict general prohibition against the return and reuse of dispensed medications, with highly specific exceptions for undelivered scripts, institutional facilities, and donation programs.

The General Rule: Non-Return and Non-Reuse

Under standard Texas Health and Safety Code provisions and TSBP rules, once a prescription drug has been dispensed and has left the physical possession of the pharmacy, it cannot be returned to stock, resold, or reused for another patient . This rule applies to all standard Class A (community) pharmacy transactions, even if the patient claims the bottle was never opened, the seal is intact, or they received the wrong medication due to a pharmacy error. While a pharmacy may accept returned medications from a patient for the sole purpose of destruction or safe disposal , these medications can never be returned to active inventory.

Will-Call Return-to-Stock (RTS) Regulations

Frequently, prescriptions are prepared, verified by a pharmacist, and placed in the "will-call" bin, but the patient never comes to pick them up. Because these medications never left the physical control of the pharmacy staff , they are not considered "dispensed" under the return-to-stock rules. They can legally be returned to active inventory for future dispensing, subject to strict guidelines under 22 TAC § 291.33 :

Pharmacist Evaluation: A pharmacist must evaluate the quality and safety of the medication before it is returned to stock (e.g., verifying it was stored under proper temperature control and has not been contaminated).

Original Dispensing Vial: The medication must be stored in the original dispensing vial (the prescription bottle). The pharmacy staff must completely remove, deface, or redact the previous patient's name, prescription number, and all other identifying information to protect patient privacy.

Prohibition on Bulk Mixing: Staff are strictly prohibited from pouring the medication back into the manufacturer's bulk stock bottle . Mixing returned tablets with bulk stock is dangerous because it combines different lot numbers and expiration dates, making it impossible to manage manufacturer recalls.

Expiration Date Calculation: When returned to stock, the medication's expiration date must be adjusted. The new expiration date is the lesser of :

One year from the original dispensing date listed on the prescription label; or

The manufacturer's original expiration date.

New Vial Upon Redispensing: When the RTS medication is eventually dispensed to a new patient, it must be placed in a brand-new prescription container, unless the previous label was completely removed without leaving adhesive residue.

Returns from Institutional / Long-Term Care Facilities

Because patients in nursing homes and other long-term care facilities (LTCFs) have their medications managed and administered by licensed healthcare professionals rather than holding them in their own physical possession, Texas law provides an exception allowing the return and reuse of certain unused medications to the dispensing pharmacy.

Conditions for Accepting LTCF Returns

To accept and reuse medications returned from a licensed healthcare facility:

No Controlled Substances: Under federal law, controlled substances (Schedules II-V) can never be returned to inventory or reused. They must be destroyed.

Original Sealed Packaging: The medication must be in its original, unopened, tamper-evident packaging. This includes the manufacturer's sealed unit-dose or single-dose blister packaging, or hermetically sealed containers. Bulk prescription vials cannot be returned.

Monitored Custody: The medication must have remained under the continuous control of the facility's licensed staff and must never have been in the physical possession of the resident.

120-Day Rule: The medication must have at least 120 days remaining before its expiration date at the time of return. This ensures that the drug has sufficient shelf life for another patient.

Exclusions: Compound medications, drugs requiring refrigeration, or drugs that are known to be highly unstable cannot be accepted for return or reuse.

Voluntary Participation: Participation in this return program is entirely voluntary. No pharmacy, facility, or consultant pharmacist is legally required to participate.

Inventory Log: The pharmacy must maintain a separate log of all returned medications, including the drug name, strength, quantity, manufacturer's lot number, and expiration date.

The Prescription Drug Donation Act

Under Texas Health and Safety Code Chapter 442 , Texas operates a voluntary Prescription Drug Donation Program to facilitate the redistribution of eligible, unused medications to indigent, uninsured, or underinsured patients.

Participating Providers: Only pharmacies, clinics, or hospitals that register with the state as "participating providers" may accept donated drugs.

Eligibility Criteria: Donated medications must be FDA-approved, unexpired, and in their original sealed unit-dose packaging. Just like facility returns, controlled substances are strictly excluded from the donation program.

Charging Limits: Participating pharmacies may charge a nominal handling fee to cover administrative costs, but they are strictly prohibited from selling the donated drugs for a profit.

Medication Disposal and Take-Back Kiosks

Many pharmacies participate in DEA-authorized take-back programs by installing secure collection kiosks where patients can drop off unwanted medications (including controlled substances) for destruction.

Kiosk Security: Kiosks must be double-locked, secured to the floor or wall, and positioned in the immediate line of sight of the pharmacy counter.

Absolute Staff Prohibition: To prevent internal diversion, pharmacy staff are strictly prohibited from touching, sorting, inventorying, or handling any medications deposited into the kiosk . Only registered DEA reverse distributors are permitted to open the kiosk, replace the inner collection liner, and transport the bags for incineration.

Summary: Will-Call RTS vs. LTCF Returns vs. Drug Donation

  • Feature Will-Call Return-to-Stock (RTS) Long-Term Care Facility (LTCF) Returns Prescription Drug Donation
  • Drug Types All schedules (Dangerous drugs & CII–CV) Non-controlled drugs only Non-controlled drugs only

Packaging Dispensing vial (patient info defaced) Manufacturer sealed unit-dose blister packaging Manufacturer sealed unit-dose blister packaging

  • Patient Possession None (Never left pharmacy) None (Held by facility staff) Variable (Must verify integrity)
  • Expiration Limit Lesser of 1 year or manufacturer date Min 120 days remaining Must be unexpired

Purpose Returned to active inventory for reuse Returned to active inventory for reuse Dispensed to indigent patients (not-for-profit)

Legal Pitfalls & Exam Traps

The Customer Mistake Return Trap: A patient realizes they were given the wrong strength of blood pressure medication, returns to the pharmacy, and hands the unopened bottle back to the pharmacist. The pharmacist realizes it was their error and wants to put the bottle back on the shelf. This is an administrative violation. Once the bottle crossed the pharmacy counter and left the staff's control, it was "dispensed" and cannot be returned to stock, regardless of whether it is unopened or was a pharmacy error. The pharmacy must quarantine the drug for destruction.

The RTS Bulk Bottle Mixing Trap: A technician is returning a will-call prescription for amoxicillin capsules to stock and pours the capsules back into the manufacturer's bulk container to clear space. This is a severe violation. Mixing RTS drugs with bulk stock compromises the pharmacy's ability to respond to manufacturer recalls and violates TSBP Rule § 291.33.